IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition

IMPACC Data Analysis Group, IMPACC Site Investigators, IMPACC Core Laboratory, IMPACC Clinical Study Team, IMPACC Network, IMPACC Steering Committee, Clinical & Data Coordinating Center (CDCC), Benjamin S. Haslund-Gourley, Kyra Woloszczuk, Jintong Hou, Jennifer Connors, Gina Cusimano, Mathew Bell, Bhavani Taramangalam, Slim Fourati, Nathan Mege, Mariana Bernui, Matthew C. Altman, Florian Krammer, Harm van BakelHolden T. Maecker, Nadine Rouphael, Joann Diray-Arce, Brian Wigdah, Michele A. Kutzler, Charles B. Cairns, Elias K. Haddad, Mary Ann Comunale, Al Ozonoff, Lauren I.R. Ehrlich, Esther Melamed, Ana Fernandez Sesma, Viviana Simon, Bali Pulendran, Kari C. Nadeau, Mark M. Davis, Grace A. McCoey, Rafick Sekaly, Lindsey R. Baden, Ofer Levy, Joanna Schaenman, Elaine F. Reed, Albert C. Shaw, David A. Hafler, Ruth R. Montgomery, Steven H. Kleinstein, Patrice M. Becker, Alison D. Augustine, Carolyn S. Calfee, David J. Erle, Michael E. Debakey, David B. Corry, Farrah Kheradmand, Mark A. Atkinson, Scott C. Brakenridge, Nelson I. Agudelo Higuita, Jordan P. Metcalf, Catherine L. Hough, William B. Messer, Monica Kraft, Chris Bime, Bjoern Peters, Carly E. Milliren, Caitlin Syphurs, Kerry McEnaney, Brenda Barton, Claudia Lentucci, Mehmet Saluvan, Ana C. Chang, Annmarie Hoch, Marisa Albert, Tanzia Shaheen, Alvin T. Kho, Shanshan Liu, Sanya Thomas, Jing Chen, Maimouna D. Murphy, Mitchell Cooney, Arash Nemati Hayati, Robert Bryant, James Abraham, Naresh Doni Jayavelu, Scott Presnell, Tomasz Jancsyk, Cole Maguire, Jingjing Qi, Brian Lee, Denise A. Esserman, Leying Guan, Jeremy Gygi, Shrikant Pawar, Anderson Brito, Gabriela K. Fragiadakis, Ravi Patel, James A. Overton, Randi Vita, Kerstin Westendorf, Casey P. Shannon, Scott J. Tebbutt, Rama V. Thyagarajan, Justin F. Rousseau, Dennis Wylie, Todd A. Triplett, Erna Kojic, Sharon Chinthrajah, Neera Ahuja, Angela J. Rogers, Maja Artandi, Linda Geng, George Yendewa, Debra L. Powell, James N. Kim, Brent Simmons, I. Michael Goonewardene, Cecilia M. Smith, Mark Martens, Amy C. Sherman, Stephen R. Walsh, Nicolas C. Issa, Ramin Salehi-Rad, Charles Dela Cruz, Shelli Farhadian, Akiko Iwasaki, Albert I. Ko, Evan J. Anderson, Aneesh K. Mehta, Jonathan E. Sevransky, Vicki Seyfert-Margolis, Aleksandra Leligdowicz, Michael A. Matthay, Jonathan P. Singer, Kirsten N. Kangelaris, Carolyn M. Hendrickson, Matthew F. Krummel, Charles R. Langelier, Prescott G. Woodruff, Matthew L. Anderson, Faheem W. Guirgis, Douglas A. Drevets, Brent R. Brown, Sarah A.R. Siegel, Zhengchun Lu, Jarrod Mosier, Hiroki Kimura, Bernard Khor, Adeeb Rahman, Daniel Stadlbauer, Jayeeta Dutta, Hui Xie, Seunghee Kim-Schulze, Ana Silvia Gonzalez-Reiche, Adriana van de Guchte, Juan Manuel Carreño, Gagandeep Singh, Ariel Raskin, Johnstone Tcheou, Dominika Bielak, Hisaaki Kawabata, Geoffrey Kelly, Manishkumar Patel, Kai Nie, Temima Yellin, Miriam Fried, Leeba Sullivan, Sara Morris, Scott Sieg, Hanno Steen, Patrick van Zalm, Benoit Fatou, Kevin Mendez, Jessica Lasky-Su, Scott R. Hutton, Greg Michelotti, Kari Wong, Meenakshi Jha, Arthur Viode, Naama Kanarek, Boryana Petrova, Yujiao Zhao, Steven E. Bosinger, Arun K. Boddapati, Greg K. Tharp, Kathryn L. Pellegrini, Elizabeth Beagle, David Cowan, Sydney Hamilton, Susan Pereira Ribeiro, Thomas Hodder, Lindsey B. Rosen, Serena Lee, Michael R. Wilson, Ravi Dandekar, Bonny Alvarenga, Jayant Rajan, Walter Eckalbar, Andrew W. Schroeder, Alexandra Tsitsiklis, Eran Mick, Yanedth Sanchez Guerrero, Christina Love, Lenka Maliskova, Michael Adkisson, Nadia Siles, Janelle Geltman, Kerin Hurley, Miti Saksena, Pratik Sinha

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

The glycosylation of IgG plays a critical role during human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, activating immune cells and inducing cytokine production. However, the role of IgM N-glycosylation has not been studied during human acute viral infection. The analysis of IgM N-glycosylation from healthy controls and hospitalized coronavirus disease 2019 (COVID-19) patients reveals increased high-mannose and sialylation that correlates with COVID-19 severity. These trends are confirmed within SARS-CoV-2-specific immunoglobulin N-glycan profiles. Moreover, the degree of total IgM mannosylation and sialylation correlate significantly with markers of disease severity. We link the changes of IgM N-glycosylation with the expression of Golgi glycosyltransferases. Lastly, we observe antigen-specific IgM antibody-dependent complement deposition is elevated in severe COVID-19 patients and modulated by exoglycosidase digestion. Taken together, this work links the IgM N-glycosylation with COVID-19 severity and highlights the need to understand IgM glycosylation and downstream immune function during human disease.

Original languageEnglish
Article number404
JournalNature communications
Volume15
Issue number1
DOIs
StatePublished - Dec 2024

Fingerprint

Dive into the research topics of 'IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition'. Together they form a unique fingerprint.

Cite this